HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neuronal over-expression of Oxr1 is protective against ALS-associated mutant TDP-43 mislocalisation in motor neurons and neuromuscular defects in vivo.

Abstract
A common pathological hallmark of amyotrophic lateral sclerosis (ALS) and the related neurodegenerative disorder frontotemporal dementia, is the cellular mislocalization of transactive response DNA-binding protein 43 kDa (TDP-43). Additionally, multiple mutations in the TARDBP gene (encoding TDP-43) are associated with familial forms of ALS. While the exact role for TDP-43 in the onset and progression of ALS remains unclear, the identification of factors that can prevent aberrant TDP-43 localization and function could be clinically beneficial. Previously, we discovered that the oxidation resistance 1 (Oxr1) protein could alleviate cellular mislocalization phenotypes associated with TDP-43 mutations, and that over-expression of Oxr1 was able to delay neuromuscular abnormalities in the hSOD1G93A ALS mouse model. Here, to determine whether Oxr1 can protect against TDP-43-associated phenotypes in vitro and in vivo, we used the same genetic approach in a newly described transgenic mouse expressing the human TDP-43 locus harbouring an ALS disease mutation (TDP-43M337V). We show in primary motor neurons from TDP-43M337V mice that genetically-driven Oxr1 over-expression significantly alleviates cytoplasmic mislocalization of mutant TDP-43. We also further quantified newly-identified, late-onset neuromuscular phenotypes of this mutant line, and demonstrate that neuronal Oxr1 over-expression causes a significant reduction in muscle denervation and neuromuscular junction degeneration in homozygous mutants in parallel with improved motor function and a reduction in neuroinflammation. Together these data support the application of Oxr1 as a viable and safe modifier of TDP-43-associated ALS phenotypes.
AuthorsMatthew G Williamson, Mattéa J Finelli, James N Sleigh, Amy Reddington, David Gordon, Kevin Talbot, Kay E Davies, Peter L Oliver
JournalHuman molecular genetics (Hum Mol Genet) Vol. 28 Issue 21 Pg. 3584-3599 (11 01 2019) ISSN: 1460-2083 [Electronic] England
PMID31642482 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© The Author(s) 2019. Published by Oxford University Press. All rights reserved. For Permissions, please email: [email protected].
Chemical References
  • DNA-Binding Proteins
  • Mitochondrial Proteins
  • OXR1 protein, human
  • TARDBP protein, human
Topics
  • Amyotrophic Lateral Sclerosis (genetics, metabolism, pathology, prevention & control)
  • Animals
  • Cytoplasm (metabolism)
  • DNA-Binding Proteins (genetics, metabolism)
  • Female
  • Humans
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Mitochondrial Proteins (genetics, metabolism)
  • Motor Neurons (metabolism)
  • Muscle Denervation
  • Muscles (innervation)
  • Mutation, Missense
  • Neuromuscular Junction (metabolism)
  • Protein Transport

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: